Related Experiment Video

Updated: Jul 24, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Workshop to identify critical windows of exposure for children's health: immune and respiratory systems work group

R R Dietert1, R A Etzel, D Chen

  • 1Department of Microbiology and Immunology and Institute of Comparative and Environmental Toxicology, Cornell University, Ithaca, New York, USA. rrdl@cornell.edu

Environmental Health Perspectives
|June 15, 2000
PubMed

Insights

Children are not small adults; developmental toxicants pose unique risks to the immune and respiratory systems in fetuses, infants, and juveniles. Understanding developmental vulnerability is key for accurate risk assessment.

Area of Science:

  • Toxicology
  • Developmental Biology
  • Immunology
  • Respiratory Medicine

Background:

  • Children's unique physiology necessitates distinct toxicological risk assessments compared to adults.
  • Developing immune and respiratory systems exhibit altered pharmacokinetics and target organ sensitivities.
  • Existing toxicological data often extrapolates from adult models, potentially underestimating risks to younger populations.

Purpose of the Study:

  • To highlight developmental toxicants more harmful to children than adults.
  • To elucidate pharmacokinetic and target organ sensitivity differences in developing systems.
  • To identify and investigate critical windows of developmental vulnerability to toxicants.

Main Methods:

  • Examining specific developmental toxicants affecting immune and respiratory systems.
  • Analyzing pharmacokinetic differences in developing versus adult systems.
  • Utilizing animal models to identify differential windows of vulnerability.
  • Applying fundamental developmental biology principles to toxicological studies.

Main Results:

  • Identified toxicants demonstrating higher toxicity in preadults compared to adults.
  • Characterized pharmacokinetic variations and altered target organ sensitivities during development.
  • Pinpointed specific developmental windows of increased susceptibility to toxic insults.
  • Demonstrated that developmental processes influence lifelong toxicological outcomes.

Conclusions:

  • Fetuses, infants, and juveniles require specialized toxicological evaluation, not simply scaled-down adult assessments.
  • Understanding developmental biology is crucial for identifying and mitigating risks from environmental toxicants.
  • The findings support the development of improved risk assessment strategies for children's environmental health.

More Related Videos

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices12:04

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...